M

Magenta Therapeutics Inc
F:3MT

Watchlist Manager
Magenta Therapeutics Inc
F:3MT
Watchlist
Price: 11.136 EUR 0.29% Market Closed
Market Cap: 368.6m EUR

Wall Street
Price Targets

3MT Price Targets Summary
Magenta Therapeutics Inc

There are no price targets for 3MT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Magenta Therapeutics Inc Competitors:
Price Targets
BBIO
BridgeBio Pharma Inc
12% Upside
ADAG
Adagene Inc
409% Upside
688105
Nanjing Vazyme Biotech Co Ltd
46% Upside
INSM
Insmed Inc
24% Upside
REGN
Regeneron Pharmaceuticals Inc
3% Upside
TNG
Transgene SA
56% Upside
AUPH
Aurinia Pharmaceuticals Inc
5% Upside
VNDA
Vanda Pharmaceuticals Inc
74% Upside

Revenue
Forecast

Revenue Estimate
Magenta Therapeutics Inc

Revenue forecast
is not available for
Magenta Therapeutics Inc

Operating Income
Forecast

Operating Income Estimate
Magenta Therapeutics Inc

Operating Income forecast
is not available for
Magenta Therapeutics Inc

Net Income
Forecast

Net Income Estimate
Magenta Therapeutics Inc

Net Income forecast
is not available for
Magenta Therapeutics Inc
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 3MT's stock price target?
Not Available

3MT doesn't have any price targets made by Wall Street professionals.

Back to Top